Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature

Author： Holstein Andreas   Stege Helger   Kovacs Peter  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.9, Iss.2, 2010-03, pp. : 225-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin aspart/insulin glargine: Localised lipoatrophy: case report

By  

Reactions Weekly, Vol. 1, Iss. 1347, 2011-01 ,pp. : 24-25

Adis International

Access to resources Recommend Favorite

Insulin Glargine: An Updated Review of its Use in the Management of Diabetes Mellitus

By Dunn C.J.   Plosker G.L.   Keating G.M.   McKeage K.   Scott L.J.  

Drugs, Vol. 63, Iss. 16, 2003-01 ,pp. : 1743-1778

Adis International

Access to resources Recommend Favorite

Insulin analogues: Lipoatrophy in paediatric patients: 4 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1339, 2011-01 ,pp. : 25-25

Adis International

Access to resources Recommend Favorite

Insulin lispro: Lipoatrophy: case report

By  

Reactions Weekly, Vol. 1, Iss. 1016, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Insulin lispro: Lipoatrophy: case report

By  

Reactions Weekly, Vol. 1, Iss. 1393, 2012-01 ,pp. : 25-26

Adis International

Access to resources Recommend Favorite